Pfizer rises nearly 2% after it seeks nod for vaccine authorization in India
A committee of experts is likely to meet this week to consider Pfizer Inc’s application seeking emergency use authorisation for its Covid vaccine in India, which the US drug maker said would only be supplied through government contracts during the pandemic phase.from Markets-Economic Times https://ift.tt/2VKYxAX
Post a Comment